(Q33386398)

26 July 2017

Incidence and causes of heparin-induced skin lesions (English)

1 reference

26 July 2017

Edelgard Lindhoff-Last

8

object named as

Edelgard Lindhoff-Last

0 references

Ralf J. Ludwig

object named as

Ralf J Ludwig

9

0 references

author name string

Marc Schindewolf

1

1 reference

26 July 2017

Svantje Schwaner

2

1 reference

26 July 2017

Manfred Wolter

3

1 reference

26 July 2017

Hartmut Kroll

4

1 reference

26 July 2017

Andreas Recke

5

1 reference

26 July 2017

Roland Kaufmann

6

1 reference

26 July 2017

Wolf-Henning Boehncke

7

1 reference

26 July 2017

Edelgard Lindhoff-Last

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

28 September 2009

1 reference

Canadian Medical Association Journal

26 July 2017

1 reference

26 July 2017

181

1 reference

26 July 2017

8

1 reference

26 July 2017

477-481

1 reference

Enoxaparin-induced skin necrosis: a fatal outcome

26 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Allergy to heparins and anticoagulants with a similar pharmacological profile: an update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Management of cutaneous type IV hypersensitivity reactions induced by heparin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

From heparins to factor Xa inhibitors and beyond

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Delayed Drug Hypersensitivity Reactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

The influence of heparin's molecular weight and the incidence of delayed type hypersensitivity reactions revisited; in response to Grims et al., Br J Dermatol 2007; 157:514-17.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Acute generalized exanthematous pustulosis from dalteparin.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Heparin-induced recurrent anaphylaxis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

High rate of skin complications due to low-molecular-weight heparins in pregnant women

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2761438

Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy

31 October 2018

1 reference

12 December 2020

Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction

1 reference

12 December 2020

Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study

1 reference

12 December 2020

Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy

1 reference

12 December 2020

Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides

1 reference

12 December 2020

Identifiers

DOI

10.1503/CMAJ.081729

1 reference

26 July 2017

1 reference

26 July 2017

1 reference